Additional file 1: of Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections

Debaveye, Sam; De Smedt, Delphine; Heirman, Bert; Kavanagh, Shane; Dewulf, Jo

doi:10.6084/m9.figshare.8299145.v1

12913_2019_4247_MOESM1_ESM.docx (4.77 MB)

Additional file 1: of Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections

journal contribution

posted on 2019-06-19, 05:00 authored by Sam Debaveye, Delphine De Smedt, Bert Heirman, Shane Kavanagh, Jo Dewulf

Background information on model inputs, assumptions and limitations, literature reviews, Life Cycle Assessment results by midpoint category and sensitivity analysis. (DOCX 4880 kb)

Funding

Flemish Innovation and Entrepreneurship (VLAIO)

History

Usage metrics

Keywords

Life cycle assessment Environmental sustainability Pharmaceutical science Paliperidone palmitate.

Licence

CC BY + CC0

Additional file 1: of Human health benefit and burden of the schizophrenia health care pathway in Belgium: paliperidone palmitate long-acting injections

Funding

Flemish Innovation and Entrepreneurship (VLAIO)

History

Usage metrics

Categories

Keywords

Licence

Exports